Skip to content

Resistance Training and Sex Hormone Concentrations During the Menstrual Cycle

Acute Effects of Resistance Training on Sex Hormone Concentrations on Different Phases of the Menstrual Cycle

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04163380
Enrollment
25
Registered
2019-11-14
Start date
2019-11-01
Completion date
2021-12-31
Last updated
2020-02-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Women's Health

Keywords

Estrogen, Progesterone, Menstrual Cycle, Resistance Training

Brief summary

Although there are numerous studies showing effects of aerobic training on sex hormone concentrations, research analyzing the fluctuation of sex hormones in response to resistance training (RT) is lacking. The objective of this project is to analyze estradiol (E2) and progesterone (P4) responses to an acute resistance training session throughout different phases of the menstrual cycle. This proposed research has strong implications for exercise prescription and for women in general, but more importantly will allow exercise physiologists, coaches, personal trainers, or nutritionists optimize exercise programming around women's menstrual cycle.

Interventions

BEHAVIORALResistance Training

Participants will exercise at the mid-point of each menstrual cycle phase (EFP- day 4, LFP- day 11, ELP- day 18 and LLP- day 25 for a 28 day menstrual cycle). Training will consist of a warm up. Intensity will be set at 70% of 1RM, and the circuit training will include 7 strength exercises: leg press, rows, back squat, weighted crunches, deadlifts, bench press, and weighted squat jumps. The participant will perform 3 sets f 10 repetitions with 30 seconds of rest

Sponsors

Southern Illinois University Edwardsville
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Participants will be blocked (four participants by block) and then randomized to start in one of the four menstrual cycle phases (EFP, LFP, ELP, or LLP). Their will be complete once they have gone through the four phases.

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
Yes

Inclusion criteria

* Eumenorrheic females * Age 18-45 years old * BMI of 18.5-34.99 kg/m2

Exclusion criteria

* Practice exercise more than 2 days/week in the last 3 months. * Cardiovascular, metabolic, pulmonary or muscular-skeletal condition * Taking medications that affect metabolism (e.g. oral contraceptives) * Irregular menstrual cycles

Design outcomes

Primary

MeasureTime frameDescription
Change in estrogen concentrationsthrough study completion, an average of 5 weeksEstrogen concentrations will be obtained from blood samples assessed using through ELISA kits
Change in progesterone concentrationsthrough study completion, an average of 5 weeksProgesterone concentrations will be obtained from blood samples assessed using through ELISA kits

Secondary

MeasureTime frameDescription
Relative body fat (%)At baseline: 1 assessment pointRelative body fat (%) will be assessed through Dual-energy X-ray Absorptiometry
Skeletal muscle mass (kg)At baseline: 1 assessment pointSkeletal muscle mass (kg) will be estimated using Dual-energy X-ray Absorptiometry values
Cardiorespiratory FitnessAt baseline: 1 assessment pointCardiorespiratory Fitness will be assessed with a cardiopulmonary exercise test using the Bruce protocol
Lean body mass (kg)At baseline: 1 assessment pointLean body mass (kg) will be assessed through Dual-energy X-ray Absorptiometry
Strength in Leg PressAt baseline: 1 assessment pointMaximal strength in leg press will be assessed using one repetition maximum test
Changes in dietthrough study completion, an average of 5 weeksDiet will be assessed using the a 24h dietary recall
Strength in Bench PressAt baseline: 1 assessment pointMaximal strength bench press will be assessed using one repetition maximum test
Fat mass (kg)At baseline: 1 assessment pointFat mass (kg) will be assessed through Dual-energy X-ray Absorptiometry

Countries

United States

Contacts

Primary ContactMaria Fernandez del Valle, PhD
marfern@siue.edu6186505905

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026